N-Guanidino Derivatives of 1,5-Dideoxy-1,5-imino-d-xylitol are Potent, Selective, and Stable Inhibitors of β-Glucocerebrosidase. 2017

Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 3508 TB, 3508, TB, Utrecht, The Netherlands.

A series of lipidated guanidino and urea derivatives of 1,5-dideoxy-1,5-imino-d-xylitol were prepared from d-xylose using a concise synthetic protocol. Inhibition assays with a panel of glycosidases revealed that the guanidino analogues display potent inhibition against human recombinant β-glucocerebrosidase with IC50 values in the low nanomolar range. Related urea analogues of 1,5-dideoxy-1,5-imino-d-xylitol were also synthesized and evaluated in the same fashion and found to be selective for β-galactosidase from bovine liver. No inhibition of human recombinant β-glucocerebrosidase was observed for the urea analogues. Computational studies provided insight into the potent activity of analogues bearing the substituted guanidine moiety in the inhibition of lysosomal glucocerebrosidase (GBA).

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005962 Glucosylceramidase A glycosidase that hydrolyzes a glucosylceramide to yield free ceramide plus glucose. Deficiency of this enzyme leads to abnormally high concentrations of glucosylceramide in the brain in GAUCHER DISEASE. EC 3.2.1.45. Glucocerebrosidase,Acid beta-Glucosidase,Glucocerebroside beta-Glucosidase,Glucosyl Ceramidase,Glucosylceramide beta-Glucosidase,Glucosylsphingosine Glucosyl Hydrolase,beta-Glucocerebrosidase,Acid beta Glucosidase,Ceramidase, Glucosyl,Glucocerebroside beta Glucosidase,Glucosyl Hydrolase, Glucosylsphingosine,Glucosylceramide beta Glucosidase,Hydrolase, Glucosylsphingosine Glucosyl,beta Glucocerebrosidase,beta-Glucosidase, Acid,beta-Glucosidase, Glucocerebroside,beta-Glucosidase, Glucosylceramide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001616 beta-Galactosidase A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1. Lactases,Dairyaid,Lactaid,Lactogest,Lactrase,beta-D-Galactosidase,beta-Galactosidase A1,beta-Galactosidase A2,beta-Galactosidase A3,beta-Galactosidases,lac Z Protein,Protein, lac Z,beta D Galactosidase,beta Galactosidase,beta Galactosidase A1,beta Galactosidase A2,beta Galactosidase A3,beta Galactosidases
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
November 2017, MedChemComm,
Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
September 1987, Carbohydrate research,
Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
November 2011, Bioorganic & medicinal chemistry letters,
Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
January 2019, Monatshefte fur chemie,
Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
August 2021, Scientific reports,
Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
April 2001, Bioorganic & medicinal chemistry letters,
Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
January 2016, ChemMedChem,
Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
January 2000, Bioorganic & medicinal chemistry,
Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
February 1994, Carbohydrate research,
Alen Sevšek, and Luka Šrot, and Jakob Rihter, and Maša Čelan, and Linda Quarles van Ufford, and Ed E Moret, and Nathaniel I Martin, and Roland J Pieters
August 1988, The Journal of antibiotics,
Copied contents to your clipboard!